Genmab A/S

GMAB | NASDAQ | 9 Obserwujący

$21.35

-1.93%

-$0.42

Obserwuj

Overview Metrics Financials

Fair Price

$01.69

Undervalued by 30.6%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Genmab A/S (GMAB) is a Danish biotechnology company specializing in the research, development, and manufacturing of monoclonal antibodies for the treatment of various types of cancer and immune-related diseases. The company is known for its innovative approaches to therapies and a robust portfolio of therapeutic antibodies undergoing clinical trials. Genmab focuses on collaborations with pharmaceutical partners and leverages its advanced technology to create medicines with the potential to revolutionize the way diseases are treated. Genmab A/S (GMAB) shares might appeal to investors seeking exponential growth in the biotechnology sector.

Feed

There are no posts to show right now.

Genmab A/S

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?